Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment. (2019)
Attributed to:
Peptide conjugated oligonucleotides for a phase I/IIa clinical trial in Spinal Muscular Atrophy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/nat.2018.0747
PubMed Identifier: 30307373
Publication URI: http://europepmc.org/abstract/MED/30307373
Type: Journal Article/Review
Volume: 29
Parent Publication: Nucleic acid therapeutics
Issue: 1
ISSN: 2159-3337